Close Menu
  • Home
  • AI News
  • AI Startups
  • Deep Learning
  • Interviews
  • Machine-Learning
  • Robotics

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

The World’s First Agentic AI-Powered Automation Platform for Quick, Versatile FedRAMP Compliance

June 24, 2025

Tricentis Leads New Period of Agentic AI to Scale Enterprise-Grade Autonomous Software program High quality

June 24, 2025

Gurobi Pronounces New AI Assistant to Present Optimization Customers with Instantaneous Assist and Assets

June 24, 2025
Facebook X (Twitter) Instagram
Smart Homez™
Facebook X (Twitter) Instagram Pinterest YouTube LinkedIn TikTok
SUBSCRIBE
  • Home
  • AI News
  • AI Startups
  • Deep Learning
  • Interviews
  • Machine-Learning
  • Robotics
Smart Homez™
Home»Deep Learning»sChemNET: A Deep Studying Framework for Predicting Small Molecule Modulators of miRNA Exercise in Illness Remedy
Deep Learning

sChemNET: A Deep Studying Framework for Predicting Small Molecule Modulators of miRNA Exercise in Illness Remedy

Editorial TeamBy Editorial TeamOctober 30, 2024Updated:October 30, 2024No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
sChemNET: A Deep Studying Framework for Predicting Small Molecule Modulators of miRNA Exercise in Illness Remedy
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email


MicroRNAs (miRNAs) play key roles in human ailments, together with most cancers and infectious ailments, by regulating gene expression. Modulating miRNAs or their gene targets with small molecules current a possible therapeutic strategy for correcting disease-related mobile dysfunctions. Nevertheless, predicting efficient small molecules for particular miRNAs is troublesome as a consequence of restricted knowledge on miRNA-small molecule interactions. Though therapeutic oligonucleotides focusing on miRNAs have proven promise, challenges in supply, stability, and toxicity stay. Small molecule focusing on gives another, but the rules governing small molecule exercise in opposition to miRNAs are nonetheless being explored, limiting predictive capabilities.

Researchers developed sChemNET, a deep-learning framework to foretell small molecules able to modulating miRNA bioactivity. In contrast to prior fashions restricted to identified small molecule-miRNA pairs, sChemNET makes use of chemical buildings to establish bioactive compounds throughout numerous chemical libraries. By integrating chemical and miRNA sequence info, sChemNET can predict small molecules influencing miRNAs, even for restricted datasets or throughout species. It highlighted vitamin D’s results on breast cancer-related miRNAs, demonstrating its potential for broad miRNA focusing on functions.

The examine leveraged the SM2miR database to compile a dataset of small molecule and miRNA associations, particularly drawing from Homo sapiens, Mus musculus, and Rattus norvegicus. Small molecules on this dataset had been mapped to PubChem CIDs, and miRNAs had been linked to miRBase identifiers. A complete of 4,244 interactions throughout 18 species had been gathered, filtering every organism’s dataset to miRNAs with no less than 5 small molecule interactions. Extra associations had been recognized by means of RNAInter, including 1,180 new small molecule-miRNA pairs for people. The Drug Repurposing Hub offered a library of small molecules with no identified miRNA interactions for baseline compounds, making a complete take a look at set for varied organisms. Chemical buildings had been represented by MACCS fingerprints, computed by means of RDKit, to make sure constant structural characterization.

A mannequin referred to as sChemNET was developed to foretell small molecule-miRNA interactions. Relying on the duty, it employed a two-layered neural community to map chemical buildings to miRNA targets, educated with or with out miRNA sequence knowledge. Hyperparameters similar to dropout, hidden items, studying fee, and regularization had been fine-tuned by means of Bayesian optimization, with Go away-One-Out cross-validation (LOOCV) used to judge predictive accuracy. In parallel, baseline strategies included chemical similarity scoring, random project, and machine studying classifiers similar to Random Forest and XGBoost, providing comparative insights into mannequin efficiency. Lastly, sChemNET’s effectiveness was validated on a potential take a look at set, using RNAInter-derived interactions for efficiency evaluation, with further analyses on drug mechanisms and enrichment.

sChemNET is a deep studying framework designed to foretell drug targets for small chemical datasets, particularly specializing in small molecules that have an effect on miRNAs and their organic targets. Combining labeled (bioactive) and unlabeled small molecule knowledge, sChemNET builds a neural community that learns from chemical buildings to foretell their impression on miRNAs. In testing, sChemNET successfully recognized bioactive molecules for miRNAs throughout a number of species, outperforming baseline fashions, even with chemically numerous datasets. This framework was additional validated experimentally, demonstrating its predictive capacity for drug-miRNA interactions, together with for medication like docetaxel affecting miR-451 in zebrafish fashions.

In conclusion, Proteins are the principle targets in prescribed drugs, but many disease-related proteins stay untreatable. This examine explores focusing on RNA, notably microRNAs (miRNAs), in its place. Regardless of understanding miRNA-disease hyperlinks, miRNA-based medication are but to be accepted. This examine introduces sChemNET, a deep studying mannequin predicting small molecules which will impression miRNA operate, validated on zebrafish embryos and human cells. sChemNET’s predictions help drug repurposing, notably for cancers, and recommend future exploration with FDA-approved medication or different chemical libraries. 


Try the Paper. All credit score for this analysis goes to the researchers of this challenge. Additionally, don’t overlook to observe us on Twitter and be part of our Telegram Channel and LinkedIn Group. If you happen to like our work, you’ll love our e-newsletter.. Don’t Neglect to affix our 55k+ ML SubReddit.

[Trending] LLMWare Introduces Mannequin Depot: An In depth Assortment of Small Language Fashions (SLMs) for Intel PCs


Sana Hassan, a consulting intern at Marktechpost and dual-degree scholar at IIT Madras, is obsessed with making use of know-how and AI to deal with real-world challenges. With a eager curiosity in fixing sensible issues, he brings a contemporary perspective to the intersection of AI and real-life options.

Hearken to our newest AI podcasts and AI analysis movies right here ➡️





Supply hyperlink

Editorial Team
  • Website

Related Posts

Microsoft Researchers Introduces BioEmu-1: A Deep Studying Mannequin that may Generate Hundreds of Protein Buildings Per Hour on a Single GPU

February 24, 2025

What’s Deep Studying? – MarkTechPost

January 15, 2025

Researchers from NVIDIA, CMU and the College of Washington Launched ‘FlashInfer’: A Kernel Library that Offers State-of-the-Artwork Kernel Implementations for LLM Inference and Serving

January 5, 2025
Misa
Trending
Machine-Learning

The World’s First Agentic AI-Powered Automation Platform for Quick, Versatile FedRAMP Compliance

By Editorial TeamJune 24, 20250

Anitian, the chief in compliance automation for cloud-first SaaS corporations, at present unveiled FedFlex™, the primary…

Tricentis Leads New Period of Agentic AI to Scale Enterprise-Grade Autonomous Software program High quality

June 24, 2025

Gurobi Pronounces New AI Assistant to Present Optimization Customers with Instantaneous Assist and Assets

June 24, 2025

Kognitos Launches Neurosymbolic AI Platform for Automating Enterprise Operations, Guaranteeing No Hallucinations and Full Governance, Backed by $25Million Sequence Billion

June 24, 2025
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Our Picks

The World’s First Agentic AI-Powered Automation Platform for Quick, Versatile FedRAMP Compliance

June 24, 2025

Tricentis Leads New Period of Agentic AI to Scale Enterprise-Grade Autonomous Software program High quality

June 24, 2025

Gurobi Pronounces New AI Assistant to Present Optimization Customers with Instantaneous Assist and Assets

June 24, 2025

Kognitos Launches Neurosymbolic AI Platform for Automating Enterprise Operations, Guaranteeing No Hallucinations and Full Governance, Backed by $25Million Sequence Billion

June 24, 2025

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

The Ai Today™ Magazine is the first in the middle east that gives the latest developments and innovations in the field of AI. We provide in-depth articles and analysis on the latest research and technologies in AI, as well as interviews with experts and thought leaders in the field. In addition, The Ai Today™ Magazine provides a platform for researchers and practitioners to share their work and ideas with a wider audience, help readers stay informed and engaged with the latest developments in the field, and provide valuable insights and perspectives on the future of AI.

Our Picks

The World’s First Agentic AI-Powered Automation Platform for Quick, Versatile FedRAMP Compliance

June 24, 2025

Tricentis Leads New Period of Agentic AI to Scale Enterprise-Grade Autonomous Software program High quality

June 24, 2025

Gurobi Pronounces New AI Assistant to Present Optimization Customers with Instantaneous Assist and Assets

June 24, 2025
Trending

Kognitos Launches Neurosymbolic AI Platform for Automating Enterprise Operations, Guaranteeing No Hallucinations and Full Governance, Backed by $25Million Sequence Billion

June 24, 2025

New TELUS Digital Survey Reveals Belief in AI is Depending on How Information is Sourced

June 24, 2025

HCLTech and AMD Forge Strategic Alliance to Develop Future-Prepared Options throughout AI, Digital and Cloud

June 24, 2025
Facebook X (Twitter) Instagram YouTube LinkedIn TikTok
  • About Us
  • Advertising Solutions
  • Privacy Policy
  • Terms
  • Podcast
Copyright © The Ai Today™ , All right reserved.

Type above and press Enter to search. Press Esc to cancel.